<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02884986</url>
  </required_header>
  <id_info>
    <org_study_id>BnaiZionMC-16-LG-009</org_study_id>
    <nct_id>NCT02884986</nct_id>
  </id_info>
  <brief_title>Analgesia in Inguinal Hernia Repair Using a Cyclooxygenase-2-specific Inhibitor</brief_title>
  <official_title>Randomised Controlled Trial - Multimodal Analgesia in Inguinal Hernia Repair Using a Cyclooxygenase-2-specific Inhibitor: A Randomised Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bnai Zion Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bnai Zion Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Acute pain is the result of activating nociceptive pathways in both the peripheral and
      central nervous system. The origin of most acute pain from surgical stimulation is the
      mechanical trauma of the local tissue and the subsequent acute inflammatory response.

      No studies have investigated the combined use of anti-inflammatory analgesics with spinal
      anaesthesia/analgesia for pre, intra and postoperative multimodal pain protection in patients
      undergoing day-case IHR. The aim of the investigators study is therefore to assess the
      efficacy of preoperative combined administration of etoricoxib and standard spinal
      anaesthesia in the reduction of postoperative pain following IHR.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Acute pain is the result of activating nociceptive pathways in both the peripheral and
      central nervous system. The origin of most acute pain from surgical stimulation is the
      mechanical trauma of the local tissue and the subsequent acute inflammatory response. Open
      inguinal hernia repair is one of the commonest surgical procedures which may provoke pain of
      variable intensity and duration.

      Etoricoxib (Arcoxia®) is a NSAID with anti-inflammatory and analgesic properties mainly
      achieved via selective peripheral COX-2 inhibition. Spinal anaesthesia using local
      anaesthetics combined with opioids affects the transmission, modulation and modification
      stages of nociceptive afferent impulses and its analgesic qualities are superior to local
      anaesthesia alone.

      No studies have investigated the combined use of anti-inflammatory analgesics with spinal
      anaesthesia/analgesia for pre, intra and postoperative multimodal pain protection in patients
      undergoing day-case IHR. The aim of the investigators study is therefore to assess the
      efficacy of preoperative combined administration of etoricoxib and standard spinal
      anaesthesia in the reduction of postoperative pain following IHR.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2015</start_date>
  <completion_date type="Actual">January 2016</completion_date>
  <primary_completion_date type="Actual">January 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain VAS Score</measure>
    <time_frame>Each four hours until 24 hours</time_frame>
    <description>In the post operative period</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Adverse Anesthesia Outcome</condition>
  <arm_group>
    <arm_group_label>Etoricoxib</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>120mg of oral Etoricoxib under the brand name Arcoxia® (Merck Sharp &amp; Dohme) one hour prior to spinal anaesthesia induction</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>120mg of oral Placebo the same amount as the drug administrated one hour prior to spinal anaesthesia induction</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Etoricoxib</intervention_name>
    <description>120mg of oral etoricoxib under the brand name Arcoxia® (Merck Sharp &amp; Dohme) one hour prior to spinal anaesthesia induction</description>
    <arm_group_label>Etoricoxib</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>120mg of placebo</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  American Society Anesthesiology Class I and II

        Exclusion Criteria:

          -  Under treatment with Non Steroid Antinflammatory Drug

          -  Under Opioid treatment

          -  Peptic ulcer

          -  Liver insufficiency

          -  Renal insufficiency

          -  Asthma

          -  Cardiovascular disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Luis A Gaitini, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Bnai Zion Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Bnai Zion Medical Center</name>
      <address>
        <city>Haifa</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 17, 2016</study_first_submitted>
  <study_first_submitted_qc>August 30, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 31, 2016</study_first_posted>
  <last_update_submitted>August 30, 2016</last_update_submitted>
  <last_update_submitted_qc>August 30, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 31, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Bnai Zion Medical Center</investigator_affiliation>
    <investigator_full_name>LUIS.GAITINI</investigator_full_name>
    <investigator_title>M.D.</investigator_title>
  </responsible_party>
  <keyword>Etoricoxib</keyword>
  <keyword>Spinal anaesthesia</keyword>
  <keyword>Postoperative pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hernia, Inguinal</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Etoricoxib</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

